Substance use disorder: Epidemiology, medical consequences and treatment

被引:4
|
作者
Fuster, Daniel [1 ]
Zuluaga, Paola [1 ]
Muga, Robert [1 ]
机构
[1] Hosp Univ Germans Trias I Pujol, Univ Autonoma Barcelona, Serv Med Interna, Unidad Adicc, Badalona, Barcelona, Spain
来源
MEDICINA CLINICA | 2024年 / 162卷 / 09期
关键词
Substance use disorder; Alcohol; Opiates; Cocaine; Cannabis; Benzodiazepines; Epidemiology; Medical consequences; Treatment; MARIJUANA SMOKING; ALCOHOL-USE; COCAINE; DRUG; IMPACT; LIVER; COMPLICATIONS; CARE;
D O I
10.1016/j.medcli.2023.11.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substance use is a common health problem, and substance use disorder, which is its most severe presentation, is associated with multiple medical consequences and a negative impact on individual and on population health. Substance use disorder needs to be addressed as any chronic medical condition; therefore, it has to be detected at the early stages and has to be properly treated to prevent drug-related harm. Internists should be able to recognize and treat intoxication and abstinence. Internists should also be able to refer the patient to state of the art long term treatment, aimed to detoxification and treatment induction to promote abstinence and prevent relapse. In this narrative review we will discuss substance use epidemiology, its main medical consequences and its treatment, with a focus on alcohol, opiates, cocaine and other stimulants, cannabis and benzodiazepines.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 50 条
  • [41] Effectiveness of substance use disorder treatment as an alternative to imprisonment
    Suvi Virtanen
    Mikko Aaltonen
    Antti Latvala
    Mats Forsman
    Paul Lichtenstein
    Zheng Chang
    BMC Psychiatry, 24
  • [42] Ketamine in Substance Use Disorder Treatment: A Narrative Review
    Famula, Anna
    Radoszewski, Jakub
    Czerwiec, Tomasz
    Sobis, Jaroslaw
    Wieckiewicz, Gniewko
    ALPHA PSYCHIATRY, 2024, 25 (02):
  • [43] Treatment Delay and Excessive Substance Use in Bipolar Disorder
    Lagerberg, Trine Vik
    Larsson, Sara
    Sundet, Kjetil
    Hansen, Charlotte B.
    Hellvin, Tone
    Andreassen, Ole A.
    Melle, Ingrid
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2010, 198 (09) : 628 - 633
  • [44] Pharmacological treatment for substance use disorder: A systematic review
    Mateu-Molla, Joaquin
    Perez-Galvez, Bartolome
    Villanueva-Blasco, Victor Jose
    ADDICTIVE BEHAVIORS, 2025, 163
  • [45] Regression to the mean in substance use disorder treatment research
    Finney, John W.
    ADDICTION, 2008, 103 (01) : 42 - 52
  • [46] The Effects of Federal Parity on Substance Use Disorder Treatment
    Busch, Susan H.
    Epstein, Andrew J.
    Harhay, Michael O.
    Fiellin, David A.
    Un, Hyong
    Leader, Deane, Jr.
    Barry, Colleen L.
    AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 (01): : 76 - 82
  • [47] A mediational model of substance use disorder treatment outcomes
    Gifford, EV
    McKellar, JD
    Saweikis, M
    Moos, RH
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 118A - 118A
  • [48] Editorial: Health equity in substance use disorder treatment
    Montgomery, LaTrice
    Friedmann, Peter
    Abraham, Amanda
    Evans, Elizabeth
    Glass, Joseph
    Ilgen, Mark
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 118
  • [49] EFFECTS OF FEDERAL PARITY ON SUBSTANCE USE DISORDER TREATMENT
    Busch, S. H.
    Epstein, A. J.
    Fiellin, D.
    Un, H.
    Leader, D., Jr.
    Harhay, M.
    Barry, C. B.
    VALUE IN HEALTH, 2013, 16 (03) : A211 - A211
  • [50] Health equity in substance use disorder treatment in Kenya
    Kiburi, Sarah Kanana
    Jaguga, Florence
    Atwoli, Lukoye
    DRUG AND ALCOHOL DEPENDENCE, 2023, 253